Description

Rade-A

Rade-A belongs to a group of medicines called gastrointestinal agents used to treat gastro-oesophageal reflux disease (GERD), acidity, heartburn, Zollinger-Ellison syndrome, Helicobacter pylori infection, irritable bowel syndrome, indigestion, duodenal and gastric ulcers. The stomach is usually protected from acid by a mucous layer. In some cases, due to excess acid production, the mucous layer gets eroded, which leads to acidity.

Each Rade-A sustain release capsule enteric coated tablet contains: Rabeprazole Sodium (20 mg); Levosulpiride (75 mg).

Gastric Fullness Discomfort Upper abdominal pain Heart Burn Regurgitation Bloating Nausea & Vomiting

Uses

• GERD – Gastro Esophaegeal Reflux Disease
• Non Ulcer Dyspepsia & Motility Disorders
• Acid Peptic Disease
• Reflux Oesophagitis
• Zollinger Elisson Syndrome (ZES)
• Acute Gastritis & Duodenitis

Rabeprazole Sodium 20 mg

• • (as enteric coated pellets)
• Proton Pump Inhibitor.
  • Suppress the gastric acid secretion
• Levosulpiride 75mg
  • (as sustained release granules)
• Antipsychotic & Prokinetic agent
  • Improves peristalsis movement in gastrum

Dosage: Rade-A once daily before breakfast for 4-8 weeks